Pharmaceutical

BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order

VANCOUVER, BC, March 8, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") today announced…

10 months ago

Smart Packaging Innovation Pushes Ophthalmic Market to $527.8 Million by 2034

NEWARK, Del., March 7, 2024 /PRNewswire/ -- The ophthalmic packaging market is poised for significant growth, as indicated by a…

10 months ago

Hospital PMI® at 56.6%; February 2024 Hospital ISM® Report On Business®

TEMPE, Ariz., March 7, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in February for the sixth consecutive month…

10 months ago

Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry

WUHAN, China, March 7, 2024 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today…

10 months ago

Tom O’Lenic joins RedShiftBio as Chief Executive Officer

Extensive Commercial Expertise and Proven Track Record of Success Tom O'Lenic's appointment marks a strategic move for RedShiftBio amidst rising…

10 months ago

Standard Industries Launches a $1 Million AI Challenge to Transform Chemical Innovation

Winning Solution Will Accelerate the Development of Medicines, Food, Supplements, and Other Everyday Essentials Applicants Can Register Here Until April 5,…

10 months ago

GE HealthCare to Spotlight Industry-Leading AI-Enabled Portfolio and Digital Solutions at HIMSS 2024

Booth (#2500) will showcase AI-enabled innovations and digital solutions that enhance clinical decision making and provide personalized patient careORLANDO, Fla.--(BUSINESS…

10 months ago

Champions Oncology’s US Laboratory has Acquired Distinguished CAP Accreditation

HACKENSACK, NJ / ACCESSWIRE / March 7, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services…

10 months ago

Gilead Sciences Aids in Reducing Cancer Care Disparities: Dale Shares Her Breast Cancer Journey and the Power of Information Sharing

NORTHAMPTON, MA / ACCESSWIRE / March 7, 2024 / Gilead SciencesFor many people living with cancer, hearing about the experiences…

10 months ago

Curium Announces First Commercial Doses in Italy of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer

PARIS, March 07, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that the first commercial…

10 months ago